Depression screening increased from 40.5 percent in 2017 to 88.8 percent in 2019; increases in screening seen in all at-risk groups
Rates of depressive and anxiety symptoms increased during pregnancy and postpartum for women with epilepsy
Hypothesis that depression is caused by low serotonin not supported; some evidence shows decrease in serotonin with antidepressant use
Quality of sleep significantly improved compared with standard care alone or sham acupuncture
Individuals with stroke have increase in depressive symptoms compared with matched controls at the assessment before stroke
Prevalence in which both parents experience mood disorders higher three to 12 months postpartum
Among teens with headache, 27 percent reported worsening of headaches, while 10 percent had new onset of headache
Studies included in a scoping review suggest that screening for parental depression is feasible in pediatric settings
Increased risk also seen among unaffected siblings of patients with either depression or IBD
Depression, worry about COVID-19, loneliness as strongly linked to hospitalization as high cholesterol, hypertension